Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →24
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
23,875
Total Claims
$2.1M
Drug Cost
1,022
Beneficiaries
$2,029
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
-97%
Opioid rate vs peers
0.6% vs 20.2% avg
+346%
Cost per patient vs peers
$2,029 vs $455 avg
+337%
Brand preference vs peers
13.7% vs 3.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.6%
Opioid Rate
140
Opioid Claims
$3,038
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,275 claims · $1.4M
Generic: 20,552 claims · $652K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 851 | $271K |
| Paliperidone Palmitate | 63 | $171K |
| Deutetrabenazine | 12 | $146K |
| Rivaroxaban | 264 | $76K |
| Insulin Glargine,hum.Rec.Anlog | 209 | $57K |
| Risperidone Microspheres | 32 | $55K |
| Aripiprazole | 20 | $48K |
| Pimavanserin Tartrate | 18 | $39K |
| Empagliflozin | 132 | $38K |
| Aripiprazole Lauroxil | 12 | $38K |
| Dulaglutide | 34 | $30K |
| Divalproex Sodium | 386 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 57 | $26K |
| Iloperidone | 19 | $25K |
| Gabapentin | 704 | $23K |
Prescribing Profile
Patient Profile
73
Avg Age
57%
Female
2.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About